Safety and Efficacy Study of Sublingual Immunotherapy (SLIT) to Treat House Dust Mite Allergic Rhinitis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

509

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2010

Conditions

Allergic Rhinitis

Interventions

DRUG

300 IR house dust mites allergen extract tablet

One sublingual tablet daily for one year

DRUG

500 IR house dust mites allergen extract tablet

One sublingual tablet daily for one year

DRUG

Placebo tablet

One sublingual tablet daily for one year